BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1129845)

  • 21. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of neuraminidase-treated and mitomycin C-treated polyoma tumour cells on the established tumour growth in CBA mice. I. An attempt at evaluation of polyoma tumour destruction using the distribution of lissamine green method.
    Porwit-Bóbr Z; Slowik M; Tomecki J
    Folia Histochem Cytochem (Krakow); 1974; 12(3-4):315-20. PubMed ID: 4141984
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of immunotherapy, chemotherapy, and surgery on tumor immunity in mice.
    Tanaka T; Sasaki N
    Gan; 1974 Oct; 65(5):395-402. PubMed ID: 4435340
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticancer properties of isoniazid & hydrazine-sulphate.
    Bhide SV
    Indian J Exp Biol; 1978 Aug; 16(8):926-8. PubMed ID: 711258
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

  • 27. Synergistic lymphocyte stimulation to tumor--specific antigens after immunization with modified tumor cells.
    Enker WE; Jacobitz JL
    Surg Forum; 1976; 27(62):154-7. PubMed ID: 1019838
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. II. Intratumor injections of neuraminidase.
    Simmons RL; Rios A
    Surgery; 1972 Apr; 71(4):556-64. PubMed ID: 5021071
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    J Natl Cancer Inst; 1973 Aug; 51(2):637-44. PubMed ID: 4765377
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas.
    Alley CD; Snodgrass MJ
    Cancer Res; 1977 Jan; 37(1):95-101. PubMed ID: 830425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice.
    Simmons RL; Rios A; Ray PK; Lundgren G
    J Natl Cancer Inst; 1971 Nov; 47(5):1087-94. PubMed ID: 5123336
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 35. Concanavalin A (NSC-143504): its action on experimental tumor cells and possible use in cancer chemotherapy.
    Lin H; Bruce WR; Walcroft MJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):319-26. PubMed ID: 1149009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified tumor cells in the immunotherapy of solid mammary tumors.
    Simmons RL; Rios A; Trites P
    Med Clin North Am; 1976 May; 60(3):551-65. PubMed ID: 1271892
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.
    Simmons RL; Rios A
    Science; 1971 Nov; 174(4009):591-3. PubMed ID: 4940021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 39. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
    Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
    Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
    Kodama T; Sendo F; Kobayashi H
    Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.